Smoking increases ER-positive breast cancer risk for women

This article originally appeared here.
Share this content:
For many, cigarette smoking is a habit formed in younger years.
For many, cigarette smoking is a habit formed in younger years.

(HealthDay News) -- Younger women who smoke appear to be at increased risk for developing estrogen receptor (ER)-positive breast cancer, according to research published online Feb. 10 in Cancer.

Masaaki Kawai, M.D., Ph.D., of the Fred Hutchinson Cancer Research Center in Seattle, and colleagues conducted a case-control study of women, aged 20 to 44 years, who were diagnosed with invasive breast cancer (ER-positive, 778; ER-negative, progesterone receptor-negative, and human epidermal growth factor-negative [triple-negative], 182) and 938 women without cancer (controls). The researchers sought to assess the association between smoking and risk of breast cancer.

The researchers found that female ever-smokers were 1.3 times more likely to develop breast cancer (95 percent confidence interval [CI], 1.1 to 1.7), including increased risk of ER-positive breast cancer (odds ratio [OR], 1.4; 95 percent CI, 1.1 to 1.8), but not triple-negative breast cancer (OR, 1.1; 95 percent CI, 0.7 to 1.6). Women who were current or recent smokers with a 10 pack-year or greater history of smoking were at increased risk for ER-positive breast cancer (OR, 1.6; 95 percent CI, 1.1 to 2.4), but not triple-negative breast cancer (OR, 1.0; 95 percent CI, 0.5 to 1.9).

"The results from this study suggest that smoking history, and particularly longer term, recent smoking, is associated with a modest increase in the risk of ER-positive breast cancer, but not with the risk of triple-negative breast cancer," the authors write.

One of the study authors received a grant from the Banyu Life Science Foundation International.

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs